Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

2.61USD
15 Apr 2014
Price Change (% chg)

$-0.13 (-4.74%)
Prev Close
$2.74
Open
$2.77
Day's High
$2.90
Day's Low
$2.49
Volume
3,464,376
Avg. Vol
1,911,839
52-wk High
$8.49
52-wk Low
$2.26

Search Stocks
CLARUS LIFESCIENCES II L P Options Exercised: 0
Trade Date: Wednesday, 30 May 2012 Price: 3.53
Title: Beneficial Owner of More than 10% Class Shares Held: 10,942,471
Type Traded: Indirect Net Change in Shares This Filing: 1,680,392

Institutional Holders

% Shares Owned: 97.84%
# of Holders: 124
Total Shares Held: 94,701,640
3 Mo. Net Change: 5,420,330
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

David Scheer

60 2010 Chairman of the Board

Milind Deshpande

56 2013 President, Chief Executive Officer, Director

Mary Kay Fenton

48 2010 Chief Financial Officer, Senior Vice President

Gautam Shah

56 2012 Executive Vice President, Chief Compliance Officer

David Apelian

47 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

48 2012 Senior Vice President, Chief Commercial Officer

Michael Kishbauch

64 2013 Director

Jason Fisherman

55 2000 Independent Director

Gary Frashier

75 2008 Independent Director

Kurt Graves

45 2012 Independent Director

Dennis Liotta

65 2008 Independent Director

Robert Van Nostrand

56 2007 Independent Director

Nicole Vitullo

55 2010 Independent Director
Search Stocks